Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CAR-20/19-T cells in relapsed or refractory B-cell malignancies, including multiple non-Hodgkin lymphoma…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies [Phase 1]
A Phase 1 clinical trial is investigating LV20.19 CAR T-cells in combination with pirtobrutinib for relapsed or refractory B-cell malignanci…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 trial evaluating frontline obinutuzumab and ibrutinib in indolent non-Hodgkin lymphoma is active but not recruiting, per ClinicalTri…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) [Phase 1, Phase 2]
A safety and preliminary efficacy study of CC-99282, alone and in combination with anti-lymphoma agents, for relapsed or refractory Non-Hodg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas [Phase 1]
Phase 1 trial evaluating pomalidomide with dose-adjusted EPOCH, with or without rituximab, for HIV-associated lymphomas; recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A pharmacokinetic study is evaluating how crushing venetoclax tablets and dissolving them in solution affects drug exposure, to assess alter…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial update evaluating busulfan, fludarabine phosphate, and post-transplant cyclophosphamide in patients with hematologi…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets [Phase 1]
This clinical trial update describes the ongoing Phase 1 study of ABBV-525 tablets in adults with B-cell malignancies. The study evaluates a…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 trial evaluating loncastuximab tesirine in combination with venetoclax for relapsed or refractory non-Hodgkin lymphoma is currentl…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]
Phase 1b/2 multisite dose-finding and expansion study of WTX-330 in adults with selected advanced or metastatic solid tumors or Non-Hodgkin …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial assessing the safety of LTZ-301 in patients with various forms of non-Hodgkin lymphoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL [Phase 2]
A Phase II trial evaluating the combination of pembrolizumab and all-trans retinoic acid for relapsed or refractory Hodgkin lymphoma and non…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. [Phase 1]
A Phase 1 trial of ARV-393 is evaluating safety and dosing for Relapsed/Refractory mature B-cell Non-Hodgkin lymphoma and Relapsed/Refractor…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation [NA]
The document updates a clinical trial evaluating an electronic health mindfulness-based music therapy intervention for patients undergoing a…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CD19-directed CAR T-cells with dual co-stimulatory 4-1BB and CD3ζ domains in relapsed/refractory aggress…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET [EARLY_Phase 1]
Early-phase clinical trial evaluating in-human CXCR4 imaging with [68Ga]-Pentixafor-PET in hematologic and solid tumors; the study is curren…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
An update on a clinical trial (NCT05425992) sponsored by the University of Colorado, Denver, studying methods to improve communication and s…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors [Phase 1]
Phase 1 safety and efficacy study of HCB101, an Fc-fusion protein targeting the SIRPα-CD47 pathway, in advanced solid tumors and refractory …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma [EARLY_Phase 1]
Phase I master protocol trial evaluating a novel combination therapy for patients with relapsed or refractory aggressive B-cell lymphomas.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy [Phase 1]
Phase 1 trial evaluating duvelisib after CAR-T therapy is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) [Phase 1]
Phase 1 dose-escalation and dose-expansion study to evaluate the safety of Azer-cel (PBCAR0191) in relapsed/refractory non-Hodgkin lymphoma …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of NB02 (POSELTINIB) as monotherapy for relapsed/refractory non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to Venetoclax
Expanded access to venetoclax is being offered for multiple hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, A…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Lifestyle Intervention of Food and Exercise for Lymphoma Survivors [NA]
A University of Miami-led clinical trial evaluating a lifestyle intervention involving diet and exercise for lymphoma survivors is currently…